HTFL
Heartflow, Inc. Common StockNASDAQHealthcare$24.83+1.35%ClosedMarket Cap: $2.13B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
31.82
P/S
12.65
EV/EBITDA
-35.04
DCF Value
$0.46
FCF Yield
-2.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
76.8%
Operating Margin
-36.4%
Net Margin
-66.3%
ROE
38.0%
ROA
-32.5%
ROIC
-19.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $49.1M | 79.5% | $-17.8M | $-24.4M | $-0.25 | — |
| FY 2025 | $176.0M | 76.8% | $-64.1M | $-116.8M | $-1.37 | — |
| Q3 2025 | $46.3M | 76.5% | $-15.1M | $-50.9M | $-0.61 | — |
| Q2 2025 | $43.4M | 75.5% | $-13.7M | $-9.2M | $-0.11 | — |
| Q1 2025 | $37.2M | 75.1% | $-17.5M | $-32.3M | $-0.40 | — |
| Q4 2024 | $35.0M | 75.0% | $-16.1M | $-33.0M | $-0.52 | — |
| FY 2024 | $125.8M | 75.1% | $-61.2M | $-96.4M | $-1.49 | — |
| Q3 2024 | $32.9M | 75.7% | $-14.9M | $-19.1M | $-0.30 | — |
| Q2 2024 | $31.1M | 76.8% | $-14.2M | $-23.4M | $-0.37 | — |
| Q1 2024 | $26.8M | 72.4% | $-16.1M | $-20.9M | $-0.33 | — |
| FY 2023 | $87.2M | 66.6% | $-72.9M | $-95.7M | $-1.94 | — |